LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Sunscreen Ingredient to Coat Implants!
Spine

Sunscreen Ingredient to Coat Implants!

November 19, 2015 2 min read Premium comments

Advertisement

Sunscreen Ingredient to Coat Implants!
Courtesy of Robert S. Donovan and Flickr
Secondary

Researchers from the University of Michigan (U-M) have found that a common ingredient in sunscreen could be an effective antibacterial coating for medical implants such as pacemakers and replacement joints. Using a coating of zinc oxide nanopyramids can disrupt the growth of methicillin-resistant Staphylococcus aureus (MRSA), reducing the film on treated materials by over 95%!

As indicated in the news release, “If the nanoparticles are shaped like a pyramid with a hexagon-shaped base, they are very effective at preventing an enzyme called beta-galactosidase from breaking down lactose into the smaller sugars glucose and galactose, which the bacteria use for fuel.”

“Shape is important, both for the enzyme and for the nanoparticles. The enzyme needs to be able to twist in order to cut the lactose into the smaller sugars. Two amino acids, or protein building blocks, sit opposite one another across a groove in the enzyme. The lactose fits into the groove, and the amino acids come together to catalyze the breakup into glucose and galactose.”

“Although more studies need to be carried out, we believe that zinc oxide nanopyramids interfere with this twisting motion, ” said Nicholas Kotov, the Joseph B. and Florence V. Cejka Professor of Chemical Engineering, whose group made the nanoparticles.

" data-large-file="https://i0.wp.com/ryortho.com/wp-content/uploads/2015/11/Sunscreen_DrJScottVanEpps_WEB.jpg?fit=250%2C339&ssl=1" src="https://i0.wp.com/ryortho.com/wp-content/uploads/2015/11/Sunscreen_DrJScottVanEpps_WEB.jpg?resize=250%2C339&ssl=1" alt="Dr. J. Scott VanEpps " width="250" height="339">
Dr. J. Scott VanEpps

“The strong antibacterial activity against MRSA and other pathogens is an exciting finding, ” said Dr. Kotov. “We want to better understand the mechanisms of the antibacterial function to fine tune its inhibitory activity and to identify the structural similarities among enzymes that pyramidal nanoparticles can inhibit.”

Scott VanEpps, M.D., Ph.D., a clinical lecturer and research fellow in the U-M Medical School’s Department of Emergency Medicine, told OTW, “Professor Kotov was able to synthesize ZnO nanoparticles with very specific shapes that could inhibit enzymes just like enzyme inhibitors that occur in nature. It was well known that ZnO had some antimicrobial properties but in this form they were much more potent. The next step was to try to link this enzyme inhibition effect with the antibacterial effect. We were surprised that the shape-specific pattern of enzyme inhibition was identical to the shape-specific pattern of bacterial/biofilm growth inhibition.”

“The layer-by-layer coating method for these antimicrobial ZnO nanoparticles can be applied to almost any material including titanium and other biomaterials used in orthopedic surgery procedures.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy